Shawn F. McCarrey
Corporate Officer/Principal at BIOSTEM TECHNOLOGIES INC
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jason Matuszewski | M | - | 18 years | |
Andrew van Vurst | M | - | 18 years | |
Michael Fortunato | M | - | 3 years | |
Amy McBride-Wendell | F | 63 | 8 years | |
Brandon Poe | M | - | 2 years | |
Ken Warrington | M | - | 5 years | |
Stacy Arnold | F | - | 6 years | |
Guido Neels | M | 75 | 9 years | |
Ivica Ducic | M | - | 7 years | |
Thomas Dugan | M | 66 | 1 years | |
Joseph Babiak | M | - | - | |
Wendy Weston | F | 48 | 4 years | |
Dave Woynarowski | M | - | 8 years | |
Patrick Daly | M | - | 1 years | |
Neal Bhattcharya | M | - | 1 years | |
Mirlene Denoyes Guerre | F | - | - | |
Larry Jones | M | - | 6 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert G. Dutcher | M | 78 |
Possis Medical, Inc.
Possis Medical, Inc. Medical SpecialtiesHealth Technology Possis Medical, Inc. develops, manufactures and markets innovative medical products such as disposable catheters. It engages in the development, manufacturing and marketing of medical devices for the cardiovascular and vascular treatment markets. It's primary product is AngioJet Rheolytic Thrombectomy System, a nonsurgical, minimally invasive catheter system used for blood clot removal from native coronary arteries, leg arteries, coronary bypass grafts and AV dialysis access grafts. The company offers its system to interventional cardiologists, interventional radiologists, vascular surgeons, nephrologists and osteopaths. It also offers XMI, XMI-RX, XMI RX +, Spiroflex, XVG, Xpeedior, DVX and AVX line of catheters. The company was founded in 1952 and is headquartered in Minneapolis, MN. | 23 years |
Irving R. Colacci | M | 71 |
Possis Medical, Inc.
Possis Medical, Inc. Medical SpecialtiesHealth Technology Possis Medical, Inc. develops, manufactures and markets innovative medical products such as disposable catheters. It engages in the development, manufacturing and marketing of medical devices for the cardiovascular and vascular treatment markets. It's primary product is AngioJet Rheolytic Thrombectomy System, a nonsurgical, minimally invasive catheter system used for blood clot removal from native coronary arteries, leg arteries, coronary bypass grafts and AV dialysis access grafts. The company offers its system to interventional cardiologists, interventional radiologists, vascular surgeons, nephrologists and osteopaths. It also offers XMI, XMI-RX, XMI RX +, Spiroflex, XVG, Xpeedior, DVX and AVX line of catheters. The company was founded in 1952 and is headquartered in Minneapolis, MN. | 23 years |
John Frederick Harper | M | 73 | 4 years | |
Peter Mariani | M | 60 | 7 years | |
Samuel M. Liang | M | 61 |
MEDRAD, Inc.
MEDRAD, Inc. Medical SpecialtiesHealth Technology Part of Bayer AG, MEDRAD, Inc. manufactures endovascular devices and injection systems for the treatment of cardiovascular diseases. The company is based in Minneapolis, MN. | 4 years |
Joseph Mandato | M | 80 | 5 years | |
James D. Gustafson | M | 68 |
Possis Medical, Inc.
Possis Medical, Inc. Medical SpecialtiesHealth Technology Possis Medical, Inc. develops, manufactures and markets innovative medical products such as disposable catheters. It engages in the development, manufacturing and marketing of medical devices for the cardiovascular and vascular treatment markets. It's primary product is AngioJet Rheolytic Thrombectomy System, a nonsurgical, minimally invasive catheter system used for blood clot removal from native coronary arteries, leg arteries, coronary bypass grafts and AV dialysis access grafts. The company offers its system to interventional cardiologists, interventional radiologists, vascular surgeons, nephrologists and osteopaths. It also offers XMI, XMI-RX, XMI RX +, Spiroflex, XVG, Xpeedior, DVX and AVX line of catheters. The company was founded in 1952 and is headquartered in Minneapolis, MN. | 18 years |
Angelo Scopelianos | M | 69 | 6 years | |
Isabelle Billet | F | 62 | 5 years | |
Jon S. Gingrich | M | 55 | 2 years | |
Gregory Davault | M | - | 5 years | |
Kevin Leach | M | 54 | - | |
Maria Martinez | F | 56 | 5 years | |
Kaila Krum | F | - | 1 years | |
Lee Robert Johnston | M | 63 | 1 years | |
Jill Schiaparelli | F | 58 | 3 years | |
Eapen Chacko | M | 76 |
Possis Medical, Inc.
Possis Medical, Inc. Medical SpecialtiesHealth Technology Possis Medical, Inc. develops, manufactures and markets innovative medical products such as disposable catheters. It engages in the development, manufacturing and marketing of medical devices for the cardiovascular and vascular treatment markets. It's primary product is AngioJet Rheolytic Thrombectomy System, a nonsurgical, minimally invasive catheter system used for blood clot removal from native coronary arteries, leg arteries, coronary bypass grafts and AV dialysis access grafts. The company offers its system to interventional cardiologists, interventional radiologists, vascular surgeons, nephrologists and osteopaths. It also offers XMI, XMI-RX, XMI RX +, Spiroflex, XVG, Xpeedior, DVX and AVX line of catheters. The company was founded in 1952 and is headquartered in Minneapolis, MN. | 6 years |
John P. Engels | M | 52 | 7 years | |
Lisa Colleran | F | 66 | - | |
Mary Brainerd | F | 70 |
Possis Medical, Inc.
Possis Medical, Inc. Medical SpecialtiesHealth Technology Possis Medical, Inc. develops, manufactures and markets innovative medical products such as disposable catheters. It engages in the development, manufacturing and marketing of medical devices for the cardiovascular and vascular treatment markets. It's primary product is AngioJet Rheolytic Thrombectomy System, a nonsurgical, minimally invasive catheter system used for blood clot removal from native coronary arteries, leg arteries, coronary bypass grafts and AV dialysis access grafts. The company offers its system to interventional cardiologists, interventional radiologists, vascular surgeons, nephrologists and osteopaths. It also offers XMI, XMI-RX, XMI RX +, Spiroflex, XVG, Xpeedior, DVX and AVX line of catheters. The company was founded in 1952 and is headquartered in Minneapolis, MN. | 7 years |
John McLaughlin | M | 72 | 2 years | |
Jules L. Fisher | M | 70 |
Possis Medical, Inc.
Possis Medical, Inc. Medical SpecialtiesHealth Technology Possis Medical, Inc. develops, manufactures and markets innovative medical products such as disposable catheters. It engages in the development, manufacturing and marketing of medical devices for the cardiovascular and vascular treatment markets. It's primary product is AngioJet Rheolytic Thrombectomy System, a nonsurgical, minimally invasive catheter system used for blood clot removal from native coronary arteries, leg arteries, coronary bypass grafts and AV dialysis access grafts. The company offers its system to interventional cardiologists, interventional radiologists, vascular surgeons, nephrologists and osteopaths. It also offers XMI, XMI-RX, XMI RX +, Spiroflex, XVG, Xpeedior, DVX and AVX line of catheters. The company was founded in 1952 and is headquartered in Minneapolis, MN. | 6 years |
Robert J. Scott | M | - |
Possis Medical, Inc.
Possis Medical, Inc. Medical SpecialtiesHealth Technology Possis Medical, Inc. develops, manufactures and markets innovative medical products such as disposable catheters. It engages in the development, manufacturing and marketing of medical devices for the cardiovascular and vascular treatment markets. It's primary product is AngioJet Rheolytic Thrombectomy System, a nonsurgical, minimally invasive catheter system used for blood clot removal from native coronary arteries, leg arteries, coronary bypass grafts and AV dialysis access grafts. The company offers its system to interventional cardiologists, interventional radiologists, vascular surgeons, nephrologists and osteopaths. It also offers XMI, XMI-RX, XMI RX +, Spiroflex, XVG, Xpeedior, DVX and AVX line of catheters. The company was founded in 1952 and is headquartered in Minneapolis, MN. | 18 years |
Rodney Young | M | 68 |
Possis Medical, Inc.
Possis Medical, Inc. Medical SpecialtiesHealth Technology Possis Medical, Inc. develops, manufactures and markets innovative medical products such as disposable catheters. It engages in the development, manufacturing and marketing of medical devices for the cardiovascular and vascular treatment markets. It's primary product is AngioJet Rheolytic Thrombectomy System, a nonsurgical, minimally invasive catheter system used for blood clot removal from native coronary arteries, leg arteries, coronary bypass grafts and AV dialysis access grafts. The company offers its system to interventional cardiologists, interventional radiologists, vascular surgeons, nephrologists and osteopaths. It also offers XMI, XMI-RX, XMI RX +, Spiroflex, XVG, Xpeedior, DVX and AVX line of catheters. The company was founded in 1952 and is headquartered in Minneapolis, MN. | 9 years |
William C. Mattison | M | 77 |
Possis Medical, Inc.
Possis Medical, Inc. Medical SpecialtiesHealth Technology Possis Medical, Inc. develops, manufactures and markets innovative medical products such as disposable catheters. It engages in the development, manufacturing and marketing of medical devices for the cardiovascular and vascular treatment markets. It's primary product is AngioJet Rheolytic Thrombectomy System, a nonsurgical, minimally invasive catheter system used for blood clot removal from native coronary arteries, leg arteries, coronary bypass grafts and AV dialysis access grafts. The company offers its system to interventional cardiologists, interventional radiologists, vascular surgeons, nephrologists and osteopaths. It also offers XMI, XMI-RX, XMI RX +, Spiroflex, XVG, Xpeedior, DVX and AVX line of catheters. The company was founded in 1952 and is headquartered in Minneapolis, MN. | 9 years |
Whitney A. McFarlin | M | 84 |
Possis Medical, Inc.
Possis Medical, Inc. Medical SpecialtiesHealth Technology Possis Medical, Inc. develops, manufactures and markets innovative medical products such as disposable catheters. It engages in the development, manufacturing and marketing of medical devices for the cardiovascular and vascular treatment markets. It's primary product is AngioJet Rheolytic Thrombectomy System, a nonsurgical, minimally invasive catheter system used for blood clot removal from native coronary arteries, leg arteries, coronary bypass grafts and AV dialysis access grafts. The company offers its system to interventional cardiologists, interventional radiologists, vascular surgeons, nephrologists and osteopaths. It also offers XMI, XMI-RX, XMI RX +, Spiroflex, XVG, Xpeedior, DVX and AVX line of catheters. The company was founded in 1952 and is headquartered in Minneapolis, MN. | 10 years |
Seymour J. Mansfield | M | 79 |
Possis Medical, Inc.
Possis Medical, Inc. Medical SpecialtiesHealth Technology Possis Medical, Inc. develops, manufactures and markets innovative medical products such as disposable catheters. It engages in the development, manufacturing and marketing of medical devices for the cardiovascular and vascular treatment markets. It's primary product is AngioJet Rheolytic Thrombectomy System, a nonsurgical, minimally invasive catheter system used for blood clot removal from native coronary arteries, leg arteries, coronary bypass grafts and AV dialysis access grafts. The company offers its system to interventional cardiologists, interventional radiologists, vascular surgeons, nephrologists and osteopaths. It also offers XMI, XMI-RX, XMI RX +, Spiroflex, XVG, Xpeedior, DVX and AVX line of catheters. The company was founded in 1952 and is headquartered in Minneapolis, MN. | 21 years |
Donald C. Wegmiller | M | 85 |
Possis Medical, Inc.
Possis Medical, Inc. Medical SpecialtiesHealth Technology Possis Medical, Inc. develops, manufactures and markets innovative medical products such as disposable catheters. It engages in the development, manufacturing and marketing of medical devices for the cardiovascular and vascular treatment markets. It's primary product is AngioJet Rheolytic Thrombectomy System, a nonsurgical, minimally invasive catheter system used for blood clot removal from native coronary arteries, leg arteries, coronary bypass grafts and AV dialysis access grafts. The company offers its system to interventional cardiologists, interventional radiologists, vascular surgeons, nephrologists and osteopaths. It also offers XMI, XMI-RX, XMI RX +, Spiroflex, XVG, Xpeedior, DVX and AVX line of catheters. The company was founded in 1952 and is headquartered in Minneapolis, MN. | 21 years |
Christopher Crisman | M | - | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 46 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Shawn F. McCarrey
- Personal Network